Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of proton pump inhibitor-based quadruple regimens for Helicobacter pylori eradication
ChiCTR-IPR-16010286Phase 4Recruiting
- Sponsor
- Sir Run-Run Shaw Hospital
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of omeprazole, pantoprazole, lansoprazole, esomeprazole and rabeprazole in Helicobacter pylori infection and chronic gastritis (7 arms), sponsored by Sir Run-Run Shaw Hospital. Primary endpoints: Total effective rate, Helicobacter pylori eradication rate and 1 more. Started Dec 2016; status: recruiting.
02
Drugs
omeprazolepantoprazolelansoprazoleesomeprazolerabeprazole
03
Conditions
Helicobacter pylori infectionchronic gastritis
Beyond the preview
Go deeper on ChiCTR-IPR-16010286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16010286.